MITK
Mitek Systems, Inc.
MITK's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over MITK overall, supported by stronger modeled upside and lower modeled downside.
MITK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MITK's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
MITK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $18.25 | — |
| Current | 39x | $18.25 | — |
| Cheap | 40x | $18.89 | +3.5% |
| Fair | 69x | $32.56 | +78% |
| Expensive | 90x | $42.14 | +131% |
Historical ranges are pointers, not guarantees.
MITK's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over MITK in the historical PE scenario, which offers more potential upside but is not a forecast.
MITK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
MITK has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
MITK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.18 | +151% |
| Q2 2026 | $0.47 | +38% |
| Q1 2026 | $0.35 | +21% |
| Q4 2025 | $0.35 | +250% |
| Q3 2025 | $0.19 | +171% |
| Q2 2025 | $0.34 | +$0.49 |
| Q1 2025 | $0.29 | +$0.45 |
| Q4 2024 | $0.10 | +$0.16 |
| Q3 2024 | $0.07 | -59% |
MITK earned $0.47 per share over the past year, up 38% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over MITK on earnings, with more consistent year-over-year improvement.
MITK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $54M | +18% |
| Q1 2026 | $54.8M | +5.6% |
| Q4 2025 | $44.2M | +19% |
| Q3 2025 | $44.8M | +3.6% |
| Q2 2025 | $45.7M | +1.7% |
| Q1 2025 | $51.9M | +11% |
| Q4 2024 | $37.3M | +0.9% |
| Q3 2024 | $43.2M | +15% |
MITK's revenue has grown year over year for 10 quarters in a row: $54M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | +13 points |
| Q1 2026 | 25% | +2.8 points |
| Q4 2025 | 12% | +21 points |
| Q3 2025 | 10% | -7.4 points |
| Q2 2025 | 8.3% | +6.7 points |
| Q1 2025 | 22% | +20 points |
| Q4 2024 | -8.3% | +11 points |
| Q3 2024 | 18% | +27 points |
MITK's operating margin was 21% last quarter, up 13 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over MITK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over MITK on profitability, with a higher operating margin.
MITK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $25.3M | +19% |
| Q1 2026 | -$2.5M | -118% |
| Q4 2025 | $6.6M | +2766% |
| Q3 2025 | $19.2M | -7.8% |
| Q2 2025 | $21.2M | +69% |
| Q1 2025 | $13.5M | +105% |
| Q4 2024 | $230K | +$9.9M |
| Q3 2024 | $20.8M | +573% |
MITK generated $49M in free cash flow over the past year, down 13% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over MITK on cash flow, with more consistent year-over-year improvement.
MITK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +174K shares |
| 1 year | +4% | +1.9M shares |
| 3 years | +4.8% | +2.2M shares |
| 5 years | +7.8% | +3.5M shares |
| Available history | +17% | +7.1M shares |
MITK has 49M diluted shares, up 4% from a year ago, despite $21M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $2M |
| Q1 2026 | $7.8M |
| Q4 2025 | $10M |
| Q3 2025 | $1.5M |
| Q2 2025 | $1,000 |
| Q1 2025 | $1,000 |
| Q4 2024 | $3.3M |
| Q3 2024 | $14.1M |
MITK spent $21M buying back its own shares over the past year, up 22% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over MITK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
MITK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.0x | Net Cash |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 7.0x | High |
| Q3 2024 | -22.8x | Net Cash |
| Q4 2023 | 35.6x | High |
| Q3 2023 | 4.4x | High |
| Q2 2023 | 2.0x | Healthy |
| Q1 2023 | 2.0x | Moderate |
MITK has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MITK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.0 | Neutral |
| Stochastic | 51.8 | Neutral |
MITK's weekly RSI is 55 (neutral) and its Stochastic is 52 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
MITK PE vs Technology Sector
| Metric | MITK | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 28x | 39% above |
| PE % | 14 | 35 | 21 pts below |
MITK is trading at 39x earnings, a 39% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over MITK on valuation relative to its sector.
MITK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.7 | 3.2% above |
| 20 week MA | $18.0 | 1.3% above |
| 50 week MA | $15.3 | 20% above |
| 100 week MA | $12.4 | 47% above |
| 200 week MA | $11.6 | 58% above |
MITK has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
MITK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.63 | $18.8 | +146% |
| 2021 | $18.8 | $16.8 | -11% |
| 2022 | $16.8 | $10.0 | -40% |
| 2023 | $10.0 | $13.0 | +30% |
| 2024 | $13.0 | $11.4 | -13% |
| 2025 | $11.4 | $10.5 | -7.1% |
| 2026 YTD | $10.5 | $18.3 | +73% |
MITK has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.